Stifel Nicolaus Restarts Ocera Therapeutics (OCRX) at Buy

December 30, 2013 7:29 AM EST Send to a Friend
Get Alerts OCRX Hot Sheet
Price: $9.09 +4.60%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 10 | New: 20
Trade OCRX Now!
Join SI Premium – FREE
Stifel Nicolaus reinstates Ocera Therapeutics (Nasdaq: OCRX) at Buy and price target of $19.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $11.70 last Fridy.




You May Also Be Interested In


Related Categories

Analyst PT Change, New Coverage

Related Entities

Stifel Nicolaus

Add Your Comment